At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GSK GlaxoSmithKline PLC
Post-Market Trading 05-07 19:45:13 EDT
44.15
+0.70
+1.61%
盘后44.00
-0.15-0.34%
19:08 EDT
High44.33
Low43.96
Vol3.10M
Open44.13
D1 Closing43.45
Amplitude0.85%
Mkt Cap90.02B
Tradable Cap86.78B
Total Shares2.04B
T/O136.90M
T/O Rate0.16%
Tradable Shares1.97B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Bioversys Announces Expansion Of Strategic Collaboration With GSK And Extension Of Its Series C Round By CHF 12.3 Million
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.